Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Active substance : vaseline
Active substance : interferon alfa-2b
Active substance : imiquimod
Topics : Skin and connective tissue cancers

Topic

Diseases and conditions (1)
Plus ...
- Skin and connective tissue diseases (1)
- Plus ...
  - Skin and connective tissue cancers (1)

Practice Guidelines and Other Guides (1)
Plus ...
- Practice guidelines (1)

Français (1)

Active substance

imiquimod (1)
interferon alfa-2b (1)
vaseline (1)
zinc (1)

Practice guidelines and other guides - 1 result

Management of basal cell carcinoma (BBC) in adults

Practice guidelines - Posted on 1/3/2004

Download abstract

Add to my selection

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

rsZBq801dJZh4kzW